Regulatory and Patents
NattoPharma strictly complies with each country’s legal and regulatory requirements to sell its products. Furthermore, it pursues regulatory approval of key claims and independent body certifications that differentiate the MenaQ7® brand of products over others and exceed requirements of functional supplements and food.
NattoPharma aggressively pursues opportunities in new geographic markets that meet sound business criteria, plus is continually adding new claims, products, applications, and usages in countries where it already sells. The company has product registrations or authorizations in key markets worldwide, including countries in Europe, North & South America, Australasia, Middle East, Asia Major, and Africa.
NattoPharma actively pursues patents in key markets and countries, as part of its overall intellectual property strategy to supplement its strong patent portfolio. NattoPharma has been able to convert its cutting-edge Vitamin K2 research into proprietary method of use patents that support and protect its efficacy claims, and add significant value to our customer’s products that use our claims to differentiate themselves in the market.
The Americas, Australia/New Zealand
Eric Anderson, SVP Global Sales and Marketing
Collene Villalobos, Sales Manager, Americas
Europe, Scandinavia, Asia, Africa
Rudi De Man, VP Sales, Europe and Asia
Gunilla Traberg, Director Nordic Accounts & EU Marketing
For further information regarding NattoPharma’s R&D activities, please contact:
VP, Global Development & Regulatory